Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 102.99%856K | 643K | 1.76M | 72.46%-477K | 82.84%-1.07M | -28.61M | -741.23%-3.66M | -1.73M | -6.25M | -1,059.08%-9.51M |
| Net profit before non-cash adjustment | 87.08%-7.46M | ---1.4M | ---1.34M | -47.94%-2.56M | -235.13%-2.16M | ---57.72M | 67.74%156K | ---1.73M | --1.6M | 5,738.00%10.32M |
| Total adjustment of non-cash items | -97.92%941K | --84K | --79K | -21.07%296K | -23.85%482K | --45.28M | 667.39%522K | --375K | --633K | 267.87%1.69M |
| -Depreciation and amortization | -81.03%439K | --85K | --95K | -70.96%124K | -78.40%135K | --2.31M | 406.45%314K | --427K | --625K | 1,359.82%5.86M |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | --0 | --42.65M | --0 | ---- | ---- | -698.76%-183.72K |
| -Disposal profit | -462.25%-154K | --0 | ---77K | ---60K | 15.00%-17K | ---27.39K | --0 | --0 | ---20K | --0 |
| -Net exchange gains and losses | 118.42%20K | --9K | ---7K | 120.69%18K | --0 | ---108.57K | --0 | ---87K | ---86K | -87,125.58%-74.84K |
| -Other non-cash items | 41.63%636K | ---10K | --68K | 511.43%214K | 219.30%364K | --449.05K | 1,980.00%208K | --35K | --114K | -2,839.86%-3.91M |
| Changes in working capital | 145.63%7.37M | --1.96M | --3.03M | 568.95%1.78M | 107.11%603K | ---16.16M | -861.51%-4.33M | ---380K | ---8.48M | -6,145.60%-21.52M |
| -Change in receivables | 469.08%7.28M | --4.75M | --4.75M | -137.76%-2.47M | 119.09%256K | --1.28M | -134.94%-603K | --6.54M | ---1.34M | -1,626.12%-6.52M |
| -Change in payables | -281.02%-5.43M | ---6.94M | ---386K | 189.93%1.85M | 101.53%53K | ---1.42M | -130.68%-2.67M | ---2.06M | ---3.47M | 247.87%543.61K |
| -Changes in other current assets | 134.46%5.52M | --4.16M | ---1.33M | 149.40%2.4M | 108.02%294K | ---16.01M | ---1.06M | ---4.86M | ---3.67M | -6,148.72%-15.55M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 93.91%-149K | -570K | 541K | 103.17%15K | 86.50%-135K | -2.45M | -520.00%-341K | -473K | -1M | -2,851.49%-1.62M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 102.28%707K | --73K | --2.3M | 79.05%-462K | 83.34%-1.21M | ---31.05M | -875.92%-4M | ---2.21M | ---7.25M | -1,166.09%-11.13M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 161.19%176K | --0 | --117K | --61K | 97.98%-2K | ---287.62K | -190.68%-282K | --0 | ---99K | -30,258.40%-1.38M |
| Net business purchase and sale | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --41.76M |
| Net investment product transactions | 15,289.45%4.17M | ---268K | ---- | ---- | ---- | --27.06K | ---- | ---- | ---- | 41.77%678.97K |
| Interest received (cash flow from investment activities) | -56.53%322K | --277K | --15K | -95.00%7K | -89.45%23K | --740.71K | 2,180.00%114K | --140K | --218K | 3,270.36%294.54K |
| Net changes in other investments | -100.29%-33K | ---4K | ---4.5M | 99.55%-11K | 83.71%4.48M | --11.37M | --2.21M | ---2.44M | --2.44M | ---870.66K |
| Investing cash flow | -60.92%4.63M | --5K | --70K | 200.00%57K | 75.98%4.5M | --11.85M | -109.14%-274K | --19K | --2.56M | 6,840.94%40.48M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 144.67%4.7M | ---712K | ---681K | 77.30%-1.07M | 417.47%7.16M | ---10.52M | 145.01%1.02M | ---4.7M | ---2.26M | -304.36%-4.65M |
| Net common stock issuance | -45.62%1.11M | --0 | --0 | -14.21%163K | 876.29%947K | --2.04M | --137K | --190K | --97K | --1.81M |
| Increase or decrease of lease financing | 86.35%-191K | ---47K | ---48K | 78.32%-49K | 88.65%-47K | ---1.4M | ---135K | ---226K | ---414K | -2,449.29%-1.31M |
| Interest paid (cash flow from financing activities) | 21.38%-957K | ---266K | ---83K | -26.29%-221K | -16.57%-387K | ---1.22M | -2,046.67%-322K | ---175K | ---332K | -579.58%-985.22K |
| Net other fund-raising expenses | -15.65%693K | --1K | --0 | --0 | --692K | --821.61K | ---- | ---- | ---- | --52.4K |
| Financing cash flow | 152.12%5.35M | ---1.02M | ---812K | 76.10%-1.17M | 388.02%8.36M | ---10.27M | 130.67%699K | ---4.91M | ---2.9M | -277.40%-5.08M |
| Net cash flow | ||||||||||
| Beginning cash position | -115.85%-3.92M | --7.53M | --6.5M | -54.76%7.62M | -115.85%-3.92M | --24.72M | 265.01%9.74M | --16.84M | --24.72M | ---- |
| Current changes in cash | 136.27%10.69M | ---946K | --1.56M | 77.75%-1.58M | 253.34%11.65M | ---29.48M | -389.62%-3.57M | ---7.1M | ---7.6M | 8,564.78%24.28M |
| Effect of exchange rate changes | -14.22%718K | --909K | ---529K | 11,350.00%458K | 57.89%-120K | --836.98K | -2,200.00%-63K | --4K | ---285K | 25,210.81%444.71K |
| End cash Position | 291.19%7.49M | --7.49M | --7.53M | -33.33%6.5M | -54.76%7.62M | ---3.92M | 56.41%6.11M | --9.74M | --16.84M | 671.88%24.72M |
| Free cash flow | 102.19%688K | --73K | --2.3M | 79.05%-462K | 83.35%-1.23M | ---31.37M | -937.18%-4.28M | ---2.21M | ---7.37M | -1,303.46%-12.5M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.